Cargando…
Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
AIM: The slow coronary flow (SCF) phenomenon was characterized by delayed perfusion of epicardial arteries, and no obvious coronary artery lesion in coronary angiography. The prognosis of patients with slow coronary flow was poor. However, there is lack of rapid, simple, and accurate method for SCF...
Autores principales: | Zhu, Yuan-Ting, Zhu, Ling-Ping, Wang, Zhen-Yu, Qiu, Xue-Ting, Wu, Wan-Zhou, Liu, Wei-Wang, Feng, Yu-Yu, Xiao, Wen-Kai, Luo, Xin, Li, Zhen-Yu, Li, Chuan-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204336/ https://www.ncbi.nlm.nih.gov/pubmed/32411450 http://dx.doi.org/10.1155/2020/7361434 |
Ejemplares similares
-
miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow
por: Chen, Tong, et al.
Publicado: (2020) -
Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020) -
Soluble Vascular Cell Adhesion Molecule-1 as an Inflammation-Related Biomarker of Coronary Slow Flow
por: Zhu, Qing, et al.
Publicado: (2023) -
The effect of coronary slow flow on left atrial structure and function
por: Shui, Zhiyuan, et al.
Publicado: (2021) -
Plasma lipoprotein(a) levels in patients with slow coronary flow
por: Yucel, Habil, et al.
Publicado: (2013)